Orsiro™ Mission™ Clinical Study Overview*
| Study Name | Study Type | Patients | Status | Primary Endpoint | Clinical Flyer (Where available) |
|---|---|---|---|---|---|
| BIOSTEMI | RCT | 1300 | Completed, 60-months FU available | TLF at 12 months | Download |
| BIOFLOW-V | RCT | 1334 | Completed, 60-months FU available | TLF at 12 months | Download |
| BIOFLOW-DAPT | RCT | 1948 | 12-month FU available | Composite of Cardiac death, Myocardial Infarction and Definite or probable Stent thrombosis at 12 months | Download |
| Taglieri et al. | Network Meta-Analysis | 99039 | - | TLF at 12 months and the longest FU available | |
| BIOFLOW-II, IV, V Pooled Analysis, Calcified Lesions | Patient-level pooled analysis | 2361 | Completed | TLF and probable/definite ST at 24 months | Download |
| BIOFLOW-II, IV, V Pooled Analysis, Complex PCI | Patient-level pooled analysis | 2350 | Completed | TLF at 36 months | |
| BIO-RESORT | RCT | 3514 | Completed, 60-month FU available | TVF at 12 months | Download |
| BIOSCIENCE | RCT | 2119 | Completed, 60-month FU available | TLF at 12 months | |
| BIOFLOW-VIII | Registry | 872 | 12 month FU available | TLF at 12 months | Download |
| SCAAR | All comers registry | 69570 | 24-month FU available | - | Download |
| BIONYX | RCT | 2488 | 36-month FU available | TVF at 12 months | |
| TPASS | RCT | 2850 | Completed, 12 months FU available | NACE at 12 months | Download |
| TICO | RCT | 3056 | Completed, primary endpoint reached | NACE at 12 months | Download |
| Madhavan et al. | Meta-Analysis | 20701 | - | TLF at mean 30 months | Download |
| Bangalore et al. BIOFLOW-II, IV, V Pooled Analysis, Calcified Lesions | Meta-Analysis | 11658 | - | TLF at 12 months | |
| Pilgrim et al | Meta-Analysis | 5780 | - | TLF at mean 24 months | |
| HOST-IDEA | RCT | 2013 | 12-month FU available | TLF at 12 months | |
| SORT OUT X | RCT | 3146 | 12-month FU available | TLF at 12 months | Download |
| SORT OUT IX | RCT | 3151 | Completed, 60-month FU available | TLF at 12 months | |
| BIOFLOW-I | FIM | 30 | Completed, 12-month FU available | LLL at 9 months | |
| BIOFLOW-II | RCT | 452 | Completed, 60-month FU available | LLL at 9 months | Download |
| BIOFLOW-III | Single arm registry | 1356 | Completed, 60-month FU available | TLF at 12 months | |
| BIOFLOW-IV | RCT | 575 | Completed, 60-month FU available | TVF at 12 months | |
| BIOFLOW-VI | RCT | 440 | Completed, 60-month FU available | LLL at 9 months | |
| BIODEGRADE | RCT | 3850 | 36-month FU available | TLF at 18 months | |
| Hattrick-OCT | RCT | 44 | Primary endpoint reached | Strut coverage at 3 months | |
| HEROES | Single arm registry | 353 | 36-month FU available | DOCE at 12 months | |
| PRISON-IV | RCT | 330 | Completed, 60-month FU available | LLL at 9 months | |
| ORIENT | RCT | 372 | 36-month FU available | LLL at 9 months | |
| BIOVASC | RCT | 764 | 24-month FU available | Composite primary endpoint | |
| BIOLUX-RCT | RCT | 210 | 18-month FU available | LLL at 6 months | |
| SMART-CHOICE | RCT | 3000 | Primary endpoint reached | MACCE at 15 months | |
| PREPARE-CALC | RCT | 200 | Completed | Strategy success and LLL at 9 months | |
| ISAR OCT | RCT | 39 | Primary endpoint reached | Strut coverage at 6 months |
Are you interested in specific study data?
*a selection of the full clinical program of the Orsiro family.
Clinical data collected with either Orsiro DES or Orsiro Mission DES device within the Orsiro family od DES clinical program.
Teleflex, the Teleflex logo, Orsiro and Orsiro Mission are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Information in this material is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative. Revised 09/2025. ©2025 Teleflex Incorporated. All rights reserved.